|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 390.02 USD | +2.94% |
|
+3.66% | +19.16% |
| Aug. 04 | Amgen Lifts Outlook on Strong 2Q Drug Sales, to End Early Development of Obesity Treatment | DJ |
| Aug. 04 | Amgen Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance | MT |
| Market Cap | 204B 177B 165B 152B 288B 19,501B 290B 1,946B 761B 9,722B 768B 751B 32,248B | P/E 2026 * |
24.9x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 246B 213B 199B 183B 346B 23,475B 349B 2,342B 916B 11,703B 924B 904B 38,820B | EV / Sales 2026 * |
6.52x | EV / Sales 2027 * | 6.24x |
| Free-Float |
99.78% | Yield 2026 * |
2.66% | Yield 2027 * | 2.81% |
Last Transcript: Amgen Inc.
| 1 day | -1.20% | ||
| 1 week | +3.66% | ||
| Current month | +1.26% | ||
| 1 month | +4.24% | ||
| 3 months | +18.25% | ||
| 6 months | +15.19% | ||
| Current year | +19.16% |
| 1 week | 375.96 |  | 397.88 |
| 1 month | 353.95 | | 398 |
| Current year | 318.21 | | 398 |
| 1 year | 269.77 | | 398 |
| 3 years | 243.46 | | 398 |
| 5 years | 198.64 | | 398 |
| 10 years | 133.64 | | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/7/26 | Tax | Executive/Senior Manager | -93 | 0.0000% | ||
| 2/26/26 | Fiscal year | Chief Operating Officer | 164,376 | 0.0305% | ||
| 2/19/26 | Sell | Controller/Auditor | 1,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.94% | +3.66% | +31.37% | +69.06% | 204B | |
| -0.51% | -6.83% | +46.35% | +148.39% | 1T | |
| +0.20% | -4.14% | +52.35% | +49.40% | 613B | |
| -0.53% | -5.10% | +24.88% | +63.57% | 433B | |
| +0.48% | -0.67% | +39.13% | +34.00% | 350B | |
| +0.08% | -3.05% | +32.29% | +39.91% | 292B | |
| +2.09% | -8.91% | +5.73% | +7.71% | 239B | |
| +1.75% | -5.79% | -0.39% | -42.69% | 206B | |
| +3.13% | +3.62% | +19.50% | +79.07% | 163B | |
| +1.52% | +3.00% | +8.17% | -27.40% | 143B | |
| Average | +0.85% | -3.30% | +25.94% | +42.10% | 364.31B | |
| Weighted average by Cap. | +0.67% | -4.09% | +34.14% | +67.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.74B 32.73B 30.52B 28.05B 53.06B 3,599B 53.56B 359B 140B 1,794B 142B 139B 5,951B | 38.66B 33.53B 31.27B 28.74B 54.37B 3,687B 54.88B 368B 144B 1,838B 145B 142B 6,097B |
| Net income | 8.21B 7.12B 6.64B 6.1B 11.54B 783B 11.65B 78.1B 30.56B 390B 30.82B 30.15B 1,294B | 8.83B 7.66B 7.14B 6.57B 12.42B 842B 12.54B 84.03B 32.88B 420B 33.17B 32.44B 1,393B |
| Net Debt | 41.67B 36.14B 33.71B 30.98B 58.6B 3,974B 59.15B 397B 155B 1,981B 157B 153B 6,572B | 36.76B 31.88B 29.73B 27.33B 51.69B 3,506B 52.18B 350B 137B 1,748B 138B 135B 5,797B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | $390.02 | +2.94% | 3,458,859 |
| 26-08-03 | $378.87 | -1.63% | 3,443,058 |
| 26-07-31 | $385.16 | -0.64% | 1,954,553 |
| 26-07-30 | $387.64 | 0.00% | 3,005,306 |
| 26-07-29 | $387.64 | -1.39% | 3,005,382 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
